Connectez-vous pour accéder aux recommandations de stratégie gagnante.
Se connecterPassez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.
Se connecter16 exigences dans 5 catégories
Inscrivez-vous pour consulter les exigences et l'analyse complètes
9 documents disponibles avec des résumés IA
This document outlines tender compliance conditions, including adherence to EU sanctions against the Russian Federation, the requirement for a joint bidders' authorization if applicable, and procedures for declaring business secrets.
This document is a form where bidders must provide the technical specifications and VAT-exclusive unit prices of the biological medicines offered, which will be valid throughout the contract period.
This document details the tender evaluation methodology, specifying that the bid cost (excluding VAT) is the sole criterion, with the lowest price receiving the maximum points.
This document is an explanatory Hankepass (ESPD) outlining the contracting authority's qualification conditions and exclusion grounds, intended for review rather than direct submission.
This document is a guide for tenderers participating in the open procurement procedure "Biological medicines II," outlining the tender parts and estimated costs.
This document outlines the technical specifications for biological medicines, including active ingredients, dosage forms, strengths, and packaging, along with delivery conditions such as transport, original packaging, and minimum shelf life.
This is a draft framework agreement for the sale and transport of biological medicines, detailing the contract's subject, validity, and payment terms, providing an overview of future contractual obligations.
This document is a power of attorney template for joint tenderers, outlining their joint and several liability and authorizing one partner to submit the tender and manage the resulting contract on behalf of the consortium.
This document is a consent form where a third party confirms that the tenderer may rely on its resources to meet the qualification conditions for the "Bioloogilised ravimid II" public procurement and commits to fulfilling the relevant contractual obligations.
Inscrivez-vous pour consulter les résumés et l'analyse des documents
This tender for biological medicines is well-structured and clear, demonstrating strong legal compliance and fairness through transparent criteria and e-procurement. While comprehensive, it lacks explicit sustainability considerations and has minor data inconsistencies.
The tender appears largely compliant with national and EU regulations, clearly defining the procedure type and CPV codes. Deadlines are reasonable, and EU sanctions compliance is explicitly required. The 'Negotiation Allowed' characteristic for an 'A' (Open) procedure is a minor ambiguity, as open procedures are typically non-negotiable.
The tender description is clear, and requirements are well-documented across various annexes. Evaluation criteria (lowest price) and performance conditions are explicitly stated, making the tender easy to understand for potential bidders. AI-extracted requirements are comprehensive and accurate.
All essential information, including title, organization, reference, estimated value, and duration (12 months for the framework agreement), is provided. The tender includes 10 relevant documents detailing technical specifications, contract terms, and submission forms. The NUTS code is missing, which is a minor omission.
The tender promotes fairness through a disclosed estimated value, reasonable submission deadlines, and objective evaluation criteria (lowest price). E-procurement is enabled, ensuring equal access, and requirements appear generic, not tailored to a specific company.
Electronic submission and e-procurement are fully supported, enhancing practicality. Financing information and duration are specified within the documents. The exact contract start date is not explicitly stated but is typically determined upon award.
Key fields are mostly populated, and dates are logical. There are no reported disputes or suspensions. The minor inconsistency regarding 'Negotiation Allowed' for an 'A' procedure and the 'Value Classified: Yes' alongside a disclosed estimated value are noted but do not significantly hinder overall consistency.
The tender does not explicitly incorporate green procurement, social aspects, or innovation focus. While this is common for medical supplies where product efficacy and safety are paramount, it represents a missed opportunity to align with broader sustainability goals.
Inscrivez-vous pour consulter les exigences et l'analyse complètes
Aucune carte de crédit requise • Configuration en 2 minutes
Bonjour ! Je suis votre assistant IA pour cet appel d'offres. Je peux vous aider à comprendre les exigences, les délais, les critères d'admissibilité et vous fournir des informations stratégiques.
Aucune carte de crédit requise